Cannara Biotech (OTCMKTS:CNBTF) Trading 1.8% Higher – What’s Next?

Cannara Biotech (OTCMKTS:CNBTF – Get Free Report)’s share price rose 1.8% on Tuesday . The stock traded as high as $1.15 and last traded at $1.15. Approximately 50,010 shares traded hands during trading, an increase of 51% from the average session volume of 33,127 shares. The stock had previously closed at $1.13.

Cannara Biotech Stock Up 1.8%

The business has a fifty day moving average price of $1.23 and a two-hundred day moving average price of $1.29.

Get Cannara Biotech alerts:

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.

Featured Stories

• Five stocks we like better than Cannara Biotech
• Shorting the Grid: Bloom Energy’s $25B AI Power Play
• SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
• Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
• 3 Dividend ETFs Built for Stability in a Volatile Market

Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.